Formulation and evaluation of acyclovir ocular inserts
- At: 2005 FIP Congress in Cairo (Egypt)
- Type: Poster
- By: ALLAM (Pharmacy Faculty, Alexandria University, Department of Pharmaceutics, Alexandria, Egypt)
- Co-author(s): El Gamal (Pharmacy Faculty, Alexandria University, ALEXANDRIA, Egypt)
Naggar (Pharmacy Faculty, Alexandria University, ALEXANDRIA, Egypt)
A common cause of blindness in developed countries is due to Herpes Simplex Virus(HSV) Type I infections.
Acyclovir ,selectively inhibits the replication of this virus .Therefore, it deemed necessary to develop Acyclovir formulations of prolonged ocular residence time. This can be achieved via development of ocular inserts.
Acyclovir inserts.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.